BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Zenshine's ZX-7101A Meets Primary Endpoint in Phase 2 Study for Adult Flu Treatment

Interim analysis of the phase 2 cohort of ZX-7101A phase 2/3 adaptive design pivotal study (registration number: CTR20221729), a multicenter, randomized, d...

April 17, 2023 | News

Zenshine's ZX-7101A meets primary endpoint in Phase 2 flu treatment study

Interim analysis of the phase 2 cohort of ZX-7101A phase 2/3 adaptive design pivotal study (registration number: CTR20221729), a multicenter, randomized, d...

April 14, 2023 | News

JW Therapeutics' Relma-cel approved for systemic lupus erythematosus trial.

SLE is a complex autoimmune disease with diverse clinical manifestations involving many organs and systems. It is estimated that China has 1 mill...

April 11, 2023 | News

Airlangga University Hospital signs MOU with Singapore's Icon Cancer Center

As the first hospital in Indonesia to cooperate with Icon Cancer Center, Airlangga University Hospital is supporting the government's efforts to promote he...

April 10, 2023 | News

Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio

Jingsong Wang, MD, PhD, Chairman of Nona Biosciences, said, " By combining our respective expertise in antibody engineering and the disease area, we a...

April 06, 2023 | News

Metabolon Launches Targeted Panels to Study Microbiome and Gut Metabolome in Health and Disease

Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and pr...

April 05, 2023 | News

Indivumed becomes Indivumed Therapeutics to advance Precision Oncology with Data and AI

After twenty years as one of the first personalized oncology companies, Indivumed today announced its evolution into Indivumed Therapeutics after the acqui...

April 05, 2023 | News

Malaria: The fight to control the world's deadliest mosquito-borne disease

Key facts In 2021, nearly half of the world's population was at risk of malaria. That year, there were an estimated 247 million cases of malari...

April 04, 2023 | Analysis

Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel

Leica Biosystems announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers with a high-perfo...

April 04, 2023 | News

Thermo Fisher Scientific and Arsenal Biosciences Collaborate for T-Cell Therapy Manufacturing

ArsenalBio recently advanced its lead product candidate into clinical manufacturing of its autologous integrated circuit T cell (ICT) therapy for...

March 29, 2023 | News

Noul Co. Ltd's The RIGHT Foundation Begins Research and Development to Aid Malaria Control

Noul Co. Ltd (CEO : David Lim) announced that it has signed an agreement with The RIGHT Foundation to conduct a global clinical studies to determine t...

March 28, 2023 | News

3DHISTECH and Epredia Open Pathology Innovation Incubator to Accelerate Advancements in Cancer Diagnostics

The aim of the Pathology Innovation Incubator, founded by Epredia and 3DHISTECH, is to develop and improve solutions that revolutionize tumor diagnostics a...

March 27, 2023 | News

Phase 1 trial of OLX72021of Treatment of Androgenic Alopecia has been approved for initiation in Australia

OliX will evaluate the safety and tolerability of OLX72021 in Phase 1 clinical trial Excellent hair growth effect is observed when used as external solu...

March 27, 2023 | News

Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application

Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has received r...

March 27, 2023 | News

Stay Connected